Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A Phase 2a, multicenter, 4-part, randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the safety, tolerability, and PK of once-daily treatment with PLN-74809 in participants with idiopathic pulmonary fibrosis.
Epistemonikos ID: 6f6b6b2db8e7f63906b1132c6737756e8cae04e8
First added on: May 07, 2024